Alterity Therapeutics Ltd.ASX: ATH

ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder

May 30, 2023 at 7:52 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment